The Sigma Enigma: In Vitro/in Silico Site-Directed Mutagenesis Studies Unveil σ1 Receptor Ligand Binding

被引:44
作者
Brune, S. [1 ]
Schepmann, D. [1 ]
Klempnauer, K-H. [2 ]
Marson, D. [3 ]
Dal Col, V. [3 ]
Laurini, E. [3 ]
Fermeglia, M. [3 ]
Wuensch, B. [1 ]
Pricl, S. [3 ,4 ]
机构
[1] Univ Munster, Inst Pharmazeut & Med Chem, D-48149 Munster, Germany
[2] Univ Munster, Inst Biochem, D-48149 Munster, Germany
[3] Univ Trieste, DEA, Mol Simulat Engn MOSE Lab, I-34127 Trieste, Italy
[4] Univ Trieste, Natl Interuniv Consortium Mat Sci & Technol INSTM, Res Unit MOSE DEA, Trieste, Italy
关键词
AMINO-ACID-RESIDUES; MOLECULAR-DYNAMICS; GENERALIZED BORN; HOMOLOGY MODEL; SIMULATIONS; EXPRESSION; DOMAIN; BRAIN; PHARMACOLOGY; STABILITY;
D O I
10.1021/bi401575g
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The sigma(1) receptor is an integral membrane protein that shares no homology with other receptor systems, has no unequivocally identified natural ligands, but appears to play critical roles in a wide variety of cell functions. While the number of reports of the possible functions of the sigma(1) receptor is increasing, almost no information about the three-dimensional structure of the receptor and/or possible modes of interaction of the sigma(1) protein with its ligands have been described. Here we performed an in vitro/in silico investigation to analyze the molecular interactions of the sigma(1) receptor with its prototypical agonist (+)-pentazocine. Accordingly, 23 mutant a, isoforms were generated, and their interactions with (+)-pentazocine were determined experimentally. All direct and/or indirect effects exerted by the mutant residues on the receptor-agonist interactions were reproduced and rationalized in silk, thus shining new light on the three-dimensional structure of the sigma(1) receptor and its ligand binding site.
引用
收藏
页码:2993 / 3003
页数:11
相关论文
共 41 条
[1]  
[Anonymous], 2014, AMBER
[2]   The sigma receptor as a ligand-regulated auxiliary potassium channel subunit [J].
Aydar, E ;
Palmer, CP ;
Klyachko, VA ;
Jackson, MB .
NEURON, 2002, 34 (03) :399-410
[3]  
Bowen Wayne D., 1993, Molecular Neuropharmacology, V3, P117
[4]   Development of a Tc-99m labeled sigma-2 receptor-specific ligand as a potential breast tumor imaging agent [J].
Choi, SR ;
Yang, B ;
Plössl, K ;
Chumpradit, S ;
Wey, SP ;
Acton, PD ;
Wheeler, K ;
Mach, RH ;
Kung, HF .
NUCLEAR MEDICINE AND BIOLOGY, 2001, 28 (06) :657-666
[5]   Photoaffinity Labeling of the Sigma-1 Receptor with N-[3-(4-Nitrophenyl)propyl]-N-dodecylamine: Evidence of Receptor Dimers [J].
Chu, Uyen B. ;
Ramachandran, Subramaniam ;
Hajipour, Abdol R. ;
Ruoho, Arnold E. .
BIOCHEMISTRY, 2013, 52 (05) :859-868
[6]   Pharmacology and Therapeutic Potential of Sigma1 Receptor Ligands [J].
Cobos, E. J. ;
Entrena, J. M. ;
Nieto, F. R. ;
Cendan, C. M. ;
Del Pozo, E. .
CURRENT NEUROPHARMACOLOGY, 2008, 6 (04) :344-366
[7]   Sigma receptor modulators: a patent review [J].
Collina, Simona ;
Gaggeri, Raffaella ;
Marra, Annamaria ;
Bassi, Andrea ;
Negrinotti, Sara ;
Negri, Francesca ;
Rossi, Daniela .
EXPERT OPINION ON THERAPEUTIC PATENTS, 2013, 23 (05) :597-613
[8]   A point-charge force field for molecular mechanics simulations of proteins based on condensed-phase quantum mechanical calculations [J].
Duan, Y ;
Wu, C ;
Chowdhury, S ;
Lee, MC ;
Xiong, GM ;
Zhang, W ;
Yang, R ;
Cieplak, P ;
Luo, R ;
Lee, T ;
Caldwell, J ;
Wang, JM ;
Kollman, P .
JOURNAL OF COMPUTATIONAL CHEMISTRY, 2003, 24 (16) :1999-2012
[9]   Performance comparison of generalized born and Poisson methods in the calculation of electrostatic solvation energies for protein structures [J].
Feig, M ;
Onufriev, A ;
Lee, MS ;
Im, W ;
Case, DA ;
Brooks, CL .
JOURNAL OF COMPUTATIONAL CHEMISTRY, 2004, 25 (02) :265-284
[10]   The Hallucinogen N,N-Dimethyltryptamine (DMT) Is an Endogenous Sigma-1 Receptor Regulator [J].
Fontanilla, Dominique ;
Johannessen, Molly ;
Hajipour, Abdol R. ;
Cozzi, Nicholas V. ;
Jackson, Meyer B. ;
Ruoho, Arnold E. .
SCIENCE, 2009, 323 (5916) :934-937